Efficacy of rasagiline for the treatment of Parkinson’s disease: an updated meta-analysis
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Medicine"
DOI: 10.1080/07853890.2017.1293285
Abstract: Abstract Objective: Rasagiline is a second-generation potent selective inhibitor of monoamine oxidase-B. The aim of the study was to analyze the effectiveness of rasagiline in treatment of Parkinson’s disease (PD), both as monotherapy and combination… read more here.
Keywords: rasagiline; treatment; updrs scores; parkinson disease ... See more keywords